KCI Corporate Tower, San Antonio, TX

KCI develops and markets innovative therapeutic healing systems that address wounds, skin breakdown, circulatory problems and pulmonary complications associated with patient immobility. Since KCI's founding in 1976, KCI has subjected many of its therapeutic products to the scrutiny of clinical studies by impartial investigators with a quest for knowledge relevant to our innovative therapies. Studies have been reported in over 160 published articles, abstracts, and peer-reviewed clinical journals, and have been presented at numerous clinical symposia. The link Prior Studies will display bibliographies of those articles and abstracts.

Today, KCI continues this tradition through the use of top-notch independent investigators and research-based institutions to conduct clinical studies of our products and therapies. The link Current Studies allows investigators of current studies involving KCI products and therapies to access pages with information pertaining to their respective studies.

KCI will continue to support robust and vital clinical investigations of its products and therapies. Studies for which we are seeking investigational sites can be found at the link Research Opportunities.